Alpha Cognition Announces Election of Dr. Robert Wills as Chairman of the Board
· Financial Post
VANCOUVER, British Columbia & DALLAS -- Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced changes to its Board of Directors. Robert Wills has been elected Chairman of the Board, succeeding Len Mertz, who has retired from the Board after years of dedicated service and leadership. Read More
Visit casino-promo.biz for more information.